ライフサイエンスコーパス: patient management

1 ifferential diagnosis is crucial for correct patient management.

2 and now multidrug resistance greatly hampers patient management.

3 T scans to clinical assessment and impact on patient management.

4 confidential feedback and alternate views on patient management.

5 serve as predictive biomarkers to help guide patient management.

6 rspective with implications for etiology and patient management.

7 assist in the design of future trials and in patient management.

8 s one of the most important steps in optimal patient management.

9 tic accuracy and new therapeutic targets for patient management.

10 entation in clinical trials and, ultimately, patient management.

11 ry arteries have significant stenoses and on patient management.

12 ortant for infection control, as well as for patient management.

13 proposed and will hopefully lead to improved patient management.

14 end points in clinical trials and to inform patient management.

15 hat might influence tailored improvements in patient management.

16 ease is a major challenge in prostate cancer patient management.

17 us reaction and treatment option to optimize patient management.

18 y in cases of morphological TCMR to optimize patient management.

19 be considered the main goal in acute stroke patient management.

20 growth factor receptor 2), which are used in patient management.

21 ntribute to more personalized and predictive patient management.

22 enotype correlations aid risk assessment and patient management.

23 ination of therapy efficacy is essential for patient management.

24 ce immunosuppressive strategies and optimize patient management.

25 notyping instead of rs12979860 would improve patient management.

26 argeted antibiotic prescription and improved patient management.

27 aning failure and lead to subsequent correct patient management.

28 so far, and have important implications for patient management.

29 rational diagnostic procedures and adequate patient management.

30 utility offers potential prognostic value in patient management.

31 ievable with phenotype alone and may improve patient management.

32 , and this procedure appears helpful for the patient management.

33 survival predictions become key elements in patient management.

34 ists who use such information to guide their patient management.

35 (18)F-FET PET as a highly relevant tool for patient management.

36 ay provide prognostic information useful for patient management.

37 ut tumor progression, because this may alter patient management.

38 d by A. tanneri and lead to more appropriate patient management.

39 erapeutic efficacy or toxicity could improve patient management.

40 s the resulting implications with respect to patient management.

41 ader will be able to apply these findings to patient management.

42 o establish a conclusive diagnosis and guide patient management.

43 provide reassurance to families, and impact patient management.

44 I are used to add more practical findings in patient management.

45 se-by-case basis may be more significant for patient management.

46 ation of MIC data, with a possible impact on patient management.

47 cific allergic sensitization is required for patient management.

48 D, which might be target for intervention in patient management.

49 would be beneficial to inform treatment and patient management.

50 on of antifungal susceptibility profiles and patient management.

51 on of biopsy specimens, and thereby, improve patient management.

52 uropean, Web-based database, reports current patient management.

53 ysicians calculated the HEART score to guide patient management.

54 nical considerations, feasibility, risk, and patient management.

55 ations for clinical trial implementation and patient management.

56 r diagnosis of HIES is important for optimal patient management.

57 treatment can benefit both public health and patient management.

58 a, and gastroparesis, posing a challenge for patient management.

59 gated for their ability to aid in individual patient management.

60 ossible to give concrete recommendations for patient management.

61 g Gram-negative bacilli (NFB) is crucial for patient management.

62 ctice, with significant utility in operative patient management.

63 blood pressure measurement measurements for patient management.

64 D backgrounds, which will potentially aid in patient management.

65 y be performed when it makes a difference to patient management.

66 role of physician judgment and insight into patient management.

67 t prognostic and therapeutic implications in patient management.

68 o inform evidence-based decisions on optimal patient management.

69 m a valuable preclinical tool to a guide for patient management.

70 cal insight and practical tools that may aid patient management.

71 ncer, 3D-PMB could have a profound effect on patient management.

72 atory diagnosis is essential for appropriate patient management.

73 cardiac diagnosis, resource utilization, and patient management.

74 nt advances in the field and their impact on patient management.

75 le, we provide evidence-based guidelines for patient management.

76 nfections is essential to enable appropriate patient management.

77 ected both initial therapeutic decisions and patient management.

78 g accurate assessment of kidney function for patient management.

79 nce-based factors and may be more useful for patient management.

80 ella and Legionella species is important for patient management.

81 d on tooth loss and may have limited use for patient management.

82 correct diagnosis will substantially affect patient management.

83 e the evolving techniques and strategies for patient management.

84 ove valuable and have an immediate impact on patient management.

85 rlying etiology informs optimized individual patient management.

86 in the transmission season and for effective patient management.

87 implications for both laboratory testing and patient management.

88 in this disease, and they have been changing patient management.

89 mples and the value of such measurements for patient management.

90 nd outlines a practical clinical approach to patient management.

91 g techniques, as well as its overall role in patient management.

92 oring any variable during the trial enhances patient management.

93 from technology configuration, staffing, and patient management.

94 sents the most significant recent advance in patient management.

95 this approach will ultimately contribute to patient management.

96 are still the main focus for decisions about patient management.

97 of anal cancer and has a relevant impact on patient management.

98 d bone recurrences, thus having an impact on patient management.

99 they influence the practical approach toward patient management.

100 T iPET remains too low to justify changes in patient management.

101 s on clinical concepts guiding diagnosis and patient management.

102 erential diagnosis is critical to the proper patient management.

103 in those with HIV is recommended for optimal patient management.

104 arch questions and shape our approach toward patient management.

105 for when this technique can be beneficial in patient management.

106 osis and supported the medical staff in case patient management.

107 treatments is important for optimisation of patient management.

108 malignant transformation might influence the patient management.

109 identify aggressive forms are essential for patient management.

110 mproving diagnostic accuracy and influencing patient management.

111 ht the importance of risk stratification for patient management.

112 networks will maximize resources and improve patient management.

113 care, is essential for disease diagnosis and patient management.

114 e more informative for clinicians in guiding patient management.

115 clinical features, with clear relevance for patient management.

116 The findings may be useful in patient management.

117 acilities could inform infection control and patient management.

118 , which may inform future stratification and patient management.

119 , based on these data, suggest approaches to patient management.

120 f AF may guide an individualized approach to patient management.

121 stress potentially useful for diagnosis and patient management.

122 g the requirement for culture and benefiting patient management.

123 ram to describe diastolic function and guide patient management.

124 ave been added to some guidelines to improve patient management.

125 sion making regarding antibiotic therapy and patient management.

126 t clinical need by allowing for risk-adapted patient management.

127 tand the relationship of these findings with patient management.

128 ging studies are mandatory for pre-operative patient management.

129 disease manifestations can critically inform patient management.

130 rapy monitoring of PVGI and has an impact on patient management.

131 n risk stratification and help guide initial patient management.

132 ort and not supplant decisions in individual patient management.

133 (18)F-FDG PET/CT and had a further impact on patient management.

134 recommendations to encourage evidence-based patient management: 1) an emphasis on medical therapies

135 rs, yield was 44%); impact on subsequent NET patient management (4 papers, change in management in 51

136 dult inpatients with suspected CDI, assuming patient management according to laboratory results.

137 nding of stress hyperlactataemia to approach patient management according to logical principles.

138 assessment of the impact of PET on intended patient management across a wide spectrum of cancer indi

139 T on referring physicians' plans of intended patient management across the spectrum of expanded cance

140 Rates of proactive patient management activities are quite low in both clin

141 orary medical practice has mainly focused on patient management after a liver injury has been induced

142 e risk-stratification and potentially refine patient management after MI.

143 formed to assess the concordance of intended patient management after NaF PET and inferred management

144 Patient management always followed the decision made wit

145 ely still will be important to individualize patient management and approaches for this are discussed

146 rovide an opportunity to optimize individual patient management and avoid unnecessary systemic toxici

147 hat are highly likely to form a component of patient management and care in the next decade.

148 (EBOV) detection is crucial for appropriate patient management and care.

149 e content of this report not only influences patient management and clinical outcomes but also serves

150 dated, could be a useful tool for individual patient management and clinical research studies.

151 This has significant consequences for patient management and counseling.

152 ry open-angle glaucoma with an algorithm for patient management and detailed recommendations for eval

153 tory may be a simple, essential component of patient management and disease diagnosis.

154 omes; however, the impact of such testing on patient management and downstream testing has emerged as

155 ous radionuclides has led to a revolution in patient management and established a foundation for expa

156 precision medicine at diagnosis can improve patient management and family counseling.

157 sease activity are urgently needed to inform patient management and for use as biomarkers of therapeu

158 children that should facilitate appropriate patient management and halt the practice of serial testi

159 tain cases a second) to identify issues with patient management and hospital processes.

160 Multispecialty patient management and implications of the study's findi

161 the detection of unstable plaque can change patient management and improve outcomes.

162 types might assist in providing personalised patient management and in selection for trials.

163 often associated conditions that complicate patient management and increase morbidity and mortality.

164 Therefore, (18)F-FDG PET may change patient management and lead to improved survival for a s

165 de clinically important information to guide patient management and monitor the response to antiangio

166 udy enrollment, important aspects related to patient management and monitoring, and standardized repo

167 dementia because of important differences in patient management and outcome.

168 urate measurement of CO is important in both patient management and research.

169 sorafenib for any reason may help to improve patient management and second-line trial design.

170 ic approaches and may cause major changes in patient management and several medical disciplines.

171 PET/CT frequently affects patient management and strongly predicts OS in NSCLC, su

172 i-institutional prospective study evaluating patient management and surgical outcomes in children and

173 nt and assessed the impact of discordance on patient management and survival.

174 tigations at relapse may potentially improve patient management and survival.

175 hese roles offer a mix of guidance regarding patient management and the appropriate use and stewardsh

176 Beyond the expected improvement in patient management and the potential impact on patient o

177 lying hepatic dysfunction, which complicates patient management and the search for safe and effective

178 e positron emission tomography scan, elderly patient management and the timing and delivery of radiot

179 iagnostic scheme, thus potentially improving patient management and therapeutic RMS outcomes.

180 sionals with unique opportunities to improve patient management and to encourage lifestyle-based stra

181 nit volume have potent influences on initial patient management and treatment.

182 propriate medical reason had a low impact on patients' management and should be avoided.

183 tals should explore ways to address patient (patient management) and hospital (case volume), when pos

184 search data relevant to BSCC valve fracture, patient management, and current clinical options.

185 itically important for accurate direction of patient management, and evokes broader genetic counselli

186 argeted and immune therapies, review current patient management, and highlight future directions.

187 ainst the virus have direct implications for patient management, and may lead to new forms of immunot

188 CFH and the benefits of proactive high-risk patient management are clearly needed.

189 y approach to preoperative and postoperative patient management are essential for successful outcomes

190 hase III trials addressing the key issues in patient management are ongoing.

191 mounting, but the clinical implications for patient management are still uncertain.

192 will be needed because the implications for patient management are uncertain.

193 rtery disease, but its effects on subsequent patient management are unclear.

194 the specific contributions of specialists to patient management are unknown, their consultation was a

195 f diagnosis in bronchoscopy units, regarding patient management, are likely to have clinical impact i

196 ffort has been made to improve and harmonize patient management as documented in several guidelines a

197 ajor implications for genetic counseling and patient management as new therapeutic options are being

198 These biomarkers have implications for patient management at recurrence.

199 e data from referring physicians on intended patient management before and after PET.

200 act dPCR could have on clinical research and patient management by earlier (trace) detection of rare

201 and delineation, thus potentially affecting patient management by improving diagnosis, prognosticati

202 MCS centers have improved patient management by introducing standardized driveline

203 Such agents have the potential to improve patient management by selecting individuals for HER2-tar

204 lse negative results and, thereby, influence patient management by selecting patients that would bene

205 (18)F-FLT PET may thus aid in personalized patient management by steering treatment modifications d

206 nts compared remote monitoring with standard patient management consisting of scheduled visits and pa

207 ity field surveillance to improve diagnosis, patient management, control, and prevention of invasive

208 Many apps involve diagnosis and patient management, creating a need for regulations and

209 alues at the 50 copies/mL cutoff drive major patient management decisions and clinical study outcomes

210 ortality after esophagectomy reflects cancer patient management decisions and may provide actionable

211 measure myocardial salvage, either to inform patient management decisions or to evaluate novel therap

212 ows, all of whom gave confidence ratings and patient management decisions, both without and with the

213 at a later time and were not used to modify patient management decisions.

214 ion and associated serological responses for patient-management decisions.

215 cal skills and assessing behavior as well as patient management during critical incidents.

216 this kind of treatment, expected outcome and patient management during MR-HIFU procedure.

217 y based on statistical models are needed for patient management during the early years following the

218 which (1)H MR spectroscopy may contribute to patient management extends to neurodegenerative diseases

219 uld potentially be used to positively affect patient management for Staphylococcus-mediated bacteremi

220 n testing is a novel noninvasive approach to patient management for the diagnosis and prediction of P

221 east cancer by a pathologist is critical for patient management for tumor staging and assessing treat

222 , the technique of liver transplantation and patient management has evolved considerably.

223 routine FFR at the time of diagnostic CA on patient management has not been determined.

224 However, its impact on patient management has not been evaluated previously.

225 ubsets have been increasingly characterized, patient management has remained disappointingly uniform.

226 anatomy- and physiology-based approaches to patient management have advantages and limitations.

227 Specific aspects of ALS patient management have been evaluated serially using a

228 t data and improvements in multidisciplinary patient management have established a standard of care a

229 iology of pancreatic cancer, and advances in patients' management have also taken place.

230 DG-PET has the potential to improve lymphoma patient management; however, its usefulness will likely

231 obstruction have different implications for patient management; however, their relative contribution

232 There was a 63% (24/38 patients) management impact, with 54% (13/24 patients) b

233 se and has the realistic potential to change patient management in 10 to 20% of cases.

234 (18)F-FDG PET/CT changed patient management in 14 cases (16%), with relevant modi

235 the time of the visit would not have changed patient management in 157 (88%) of these, although seein

236 The results of staging PET had an impact on patient management in 37% of patients (P < 0.003).

237 PET/CT examination results influenced patient management in 48% of cases (34/71).

238 idence in about 60% of cases, to a change in patient management in about 60% of cases, and specifical

239 Contact resulted in attending-led changes in patient management in one-third of cases.

240 T scans to clinical assessment and impact on patient management in patients with colorectal cancer.

241 se models have been shown to be effective in patient management in programs in resource-limited setti

242 ialized settings and are presented to assist patient management in such settings.

243 cers metastasise, and their implications for patient management in the 21st century.

244 early coronary CTA may significantly improve patient management in the emergency department.

245 mmonly used in the clinic, may be useful for patient management in the event of future nCoV infection

246 Sequencing results altered patient management in the majority of suspected cases.

247 or "high-complexity" treatment decisions in patient management in the presence of advanced healthcar

248 ogy, diverse clinical phenotypes and optimal patient management including novel therapies.

249 measures may have important implications for patient management, including RVOT reconstruction, at th

250 developed the Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-

251 etect additional disease and, if so, whether patient management is altered.

252 chemia is a major cause of brain damage, and patient management is complicated by the paradoxical inj

253 Patient management is difficult due to the absence of pa

254 A coordinated team approach for patient management is essential.

255 At the present time, when patient management is increasingly based on the extent a

256 Patient management is therefore centered on accurate dia

257 Healthcare information, and to some extent patient management, is progressing toward a wireless dig

258 ection in case of ALF, though improvement of patient management may have contributed.

259 We conclude that routine TBI patient management may limit the clinical utility of blo

260 Consequently, to improve patient management modalities, a better understanding of

261 of lung-protective strategies may complicate patient management, motivating a search for better lung-

262 is recommended for screening/diagnosing and patient management of diabetes.

263 ill give providers the options for improving patient management on the basis of pharmacogenetic data.

264 formation from the monitor was used to guide patient management only in the Chronicle group.

265 ng for coccidioidomycosis might be useful in patient management or as a research tool.

266 of screening studies are unlikely to change patient management or the intensity of risk factor reduc

267 athing trial provides additional guidance in patient management over tests used for deciding when to

268 edside and the bench and leading to improved patient management paradigms.

269 fying these patients at biopsy might improve patient management, particularly with regard to active s

270 in vivo may have important implications for patient management, patient selection for trials, and to

271 ases, and increased surgeon comfort with the patient management plan in 95% (94 of 99) of cases.

272 or clinicians in choosing the most effective patient management plan that maximizes survivorship and

273 profiling of patients and the development of patient management protocols.

274 n 7 of 109 patients (6.4%), thereby altering patient management recommendations with regard to freque

275 tions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care

276 trains with on-site rapid diagnosis used for patient management, shortening the times between the eme

277 d lead to a clinically significant change in patient management should be confirmed by subsequent his

278 patient selection, operative technique, and patient management strategies have been refined, leading

279 rformed before these data can be included in patient management strategies.

280 sk and improve survival by informing post-LT patient management strategies.

281 information gained from routine FFR affects patient management strategy and clinical outcome.

282 ents, introducing an additional challenge in patient management, such as ensuring an optimal adherenc

283 tional Minimum Dataset, the Geelong Hospital patient management system in Australia, and purpose-buil

284 To optimize patient management, there is a great need to accurately

285 In addition to optimizing individual patient management, these baseline resistance data enabl

286 rs in which MR spectroscopy has an impact on patient management, together with a critical considerati

287 e understanding of disease relationships and patient management towards improved clinical outcomes.

288 Patient management vignettes varied by patient race or s

289 l information that could significantly alter patient management, warranting further investigation for

290 Additionally, the influence of SPECT/CT on patient management was evaluated.

291 the impact of each of the 12 indications on patients' management was evaluated.

292 cost of the devices, ECG interpretation, and patient management were captured and used to generate th

293 g inpatient care; significant alterations in patient management were noted in one-third of cases in w

294 severity, computed tomography findings, and patient management were registered.

295 e difficult to make informed decisions about patient management when the precise diagnosis remains un

296 rtened and may be beneficial to patients and patient management while reducing the radiation exposure

297 The future of bladder cancer patient management will rely on the use of molecular tes

298 Though residents frequently discussed patient management with attending physicians on randomly

299 osis and XDR tuberculosis greatly complicate patient management within resource-poor national tubercu

300 diate outcomes, such as a positive change in patient management, would be more efficient and appropri